HK1099360A1 - Assay - Google Patents

Assay

Info

Publication number
HK1099360A1
HK1099360A1 HK07102438.9A HK07102438A HK1099360A1 HK 1099360 A1 HK1099360 A1 HK 1099360A1 HK 07102438 A HK07102438 A HK 07102438A HK 1099360 A1 HK1099360 A1 HK 1099360A1
Authority
HK
Hong Kong
Prior art keywords
species
immobilised
binding
analyte
labelled
Prior art date
Application number
HK07102438.9A
Other languages
English (en)
Inventor
Balbir Raj
Original Assignee
Inverness Medical Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0328892A external-priority patent/GB0328892D0/en
Application filed by Inverness Medical Switzerland filed Critical Inverness Medical Switzerland
Publication of HK1099360A1 publication Critical patent/HK1099360A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
HK07102438.9A 2003-12-12 2007-03-05 Assay HK1099360A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0328892A GB0328892D0 (en) 2003-12-12 2003-12-12 Positive signal assay for analytes
US58511804P 2004-07-01 2004-07-01
PCT/GB2004/005146 WO2005059547A2 (fr) 2003-12-12 2004-12-10 Essai

Publications (1)

Publication Number Publication Date
HK1099360A1 true HK1099360A1 (en) 2007-08-10

Family

ID=34702506

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07102438.9A HK1099360A1 (en) 2003-12-12 2007-03-05 Assay

Country Status (9)

Country Link
US (2) US7901949B2 (fr)
EP (1) EP1706743B1 (fr)
JP (1) JP4624364B2 (fr)
AT (1) ATE449337T1 (fr)
AU (1) AU2004298660B2 (fr)
CA (1) CA2548164C (fr)
DE (1) DE602004024236D1 (fr)
HK (1) HK1099360A1 (fr)
WO (1) WO2005059547A2 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669052B2 (en) * 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US8470608B2 (en) * 2008-05-20 2013-06-25 Rapid Pathogen Screening, Inc Combined visual/fluorescence analyte detection test
GB0524746D0 (en) * 2005-12-03 2006-01-11 Inverness Medical Switzerland Assay device and method
CN101021526B (zh) 2007-03-16 2012-01-25 艾博生物医药(杭州)有限公司 一种直观显示检测结果的装置和方法
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US20110086359A1 (en) * 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
GB0913258D0 (en) 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
ES2791604T3 (es) 2012-07-16 2020-11-05 Ct Disease Contr & Prevention Kits de detección de lectura directa para contaminación de superficie por fármacos antineoplásicos
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
CN104736566A (zh) * 2012-08-21 2015-06-24 奥索临床诊断有限公司 帕潘立酮半抗原的抗体及其用途
CN107253993B (zh) 2012-08-21 2021-10-22 詹森药业有限公司 奥氮平的抗体及其用途
CA2882594C (fr) * 2012-08-21 2019-07-16 Ortho-Clinical Diagnostics, Inc. Anticorps diriges contre la risperidone et leur utilisation
WO2014031584A1 (fr) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Haptènes d'aripiprazole et leur utilisation dans des dosages immunologiques
AU2013305907B2 (en) 2012-08-21 2018-01-18 Saladax Biomedical Inc. Antibodies to quetiapine and use thereof
CA2882597C (fr) * 2012-08-21 2020-04-14 Ortho-Clinical Diagnostics, Inc. Anticorps diriges contre des haptenes de quetiapine et leur utilisation
EP2888285B1 (fr) 2012-08-21 2024-04-17 Janssen Pharmaceutica NV Anticorps dirigés contre des haptènes d'aripiprazole et leur utilisation
CA2882490A1 (fr) * 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Anticorps diriges contre la paliperidone et leur utilisation
AU2013305884B2 (en) * 2012-08-21 2017-10-05 Saladax Biomedical Inc. Antibodies to risperidone haptens and use thereof
CN104755093B (zh) 2012-08-21 2018-11-16 詹森药业有限公司 奥氮平半抗原的抗体及其用途
ES2666000T3 (es) 2012-08-21 2018-04-30 Janssen Pharmaceutica, N.V. Anticuerpos para aripiprazol y uso de los mismos
US10890590B2 (en) 2012-09-27 2021-01-12 Ellume Limited Diagnostic devices and methods
CN108051590B (zh) 2013-09-13 2020-12-11 Symbolics有限责任公司 运用二维试验和对照信号读出模式的侧向层析检测
WO2016115608A1 (fr) 2015-01-22 2016-07-28 Ellume Pty Ltd Dispositifs pour l'établissement de diagnostic et méthodes permettant d'atténuer l'effet crochet et utilisation de ceux-ci
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
EP3390449A1 (fr) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Anticorps anti-rispéridone et leur utilisation
WO2017106508A1 (fr) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Anticorps dirigés contre la quétiapine et utilisation associée
US10871485B2 (en) 2018-04-13 2020-12-22 Rarecyte, Inc. Kits for labeling of biomarkers and methods of using the same
CN112730825B (zh) * 2020-12-17 2022-09-06 北京丹大生物技术有限公司 一种用于检测利培酮和/或9-羟基利培酮的检测试剂和检测试剂盒

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
GB8903627D0 (en) 1989-02-17 1989-04-05 Unilever Plc Assays
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5296347A (en) * 1991-02-08 1994-03-22 Ciba Corning Diagnostics Corp. Bridge immunoassay
WO1992018868A1 (fr) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Inhibiteurs de 'liaison croisee' et leurs utilisations
US5451504A (en) 1991-07-29 1995-09-19 Serex, Inc. Method and device for detecting the presence of analyte in a sample
US6037127A (en) 1994-03-31 2000-03-14 E. I. Du Pont De Nemours And Company Method for detection of non-denatured nucleic acid fragments
WO1995027081A1 (fr) * 1994-03-31 1995-10-12 E.I. Du Pont De Nemours And Company Methode de detection de fragments d'acide nucleique
US5874216A (en) * 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
DE69624920T2 (de) 1996-09-27 2003-09-18 Inverness Medical Switzerland Testreagentien und Testvorrichtungen
SE9704933D0 (sv) * 1997-12-30 1997-12-30 Pharmacia & Upjohn Diag Ab Metod som utnyttjar en ny kalibrator och test kit som innehåller kalibratorn
US6753189B1 (en) 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
US6414133B1 (en) * 1998-10-13 2002-07-02 Ventana Medical Systems, Inc. Multiple fusion probes
DE19927783A1 (de) * 1999-06-18 2000-12-21 Roche Diagnostics Gmbh Element zur Bestimmung eines Analyts in einer Flüssigkeit, entsprechendes Bestimmungsverfahren unter Verwendung des Elementes sowie Kit zur Bestimmugn eines Analyts
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US6699722B2 (en) * 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US7029918B2 (en) * 2002-01-25 2006-04-18 Roche Diagnostics Operations, Inc. Water-soluble derivatives of lipophilic drugs
US8101429B2 (en) * 2003-06-03 2012-01-24 Siemens Healthcare Diagnostics Inc. Native analyte as a reference in lateral flow assays

Also Published As

Publication number Publication date
JP4624364B2 (ja) 2011-02-02
US7901949B2 (en) 2011-03-08
CA2548164C (fr) 2013-10-08
US20070015290A1 (en) 2007-01-18
DE602004024236D1 (en) 2009-12-31
EP1706743B1 (fr) 2009-11-18
AU2004298660A1 (en) 2005-06-30
JP2007514157A (ja) 2007-05-31
WO2005059547A3 (fr) 2005-11-03
WO2005059547A2 (fr) 2005-06-30
EP1706743A2 (fr) 2006-10-04
AU2004298660B2 (en) 2010-04-22
CA2548164A1 (fr) 2005-06-30
US20110223690A1 (en) 2011-09-15
ATE449337T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
HK1099360A1 (en) Assay
EP1767941A4 (fr) Appareil chromatographique de détection, procédé de test et kit utilisant celui-ci
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
NO20025371L (no) Forbedringer til fluorescense polymer-QTL tiln¶rming til biodetektering
DE60136034D1 (de) Molekular-Modifikations-Assays
WO2004041061A3 (fr) Substrats, dispositifs et procedes d'analyses cellulaires
CA2566040A1 (fr) Procede pour elargir la plage de mesure dynamique d'elements servant a realiser des tests notamment immunologiques, bases sur des reactions de fixation specifiques
WO2005047863A3 (fr) Substrats, dispositifs et procedes de dosages cellulaires
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2006071970A3 (fr) Procedes de detection d'analytes dans un echantillon
WO2007076013A3 (fr) Dosage immunologique de l'homocysteine
WO2005079420A3 (fr) Dosage d'agglutination d'exclusion chromatographique et leurs methodes d'utilisation
ATE405837T1 (de) Festphase immunochromatographische testverfahren
EP1138781A3 (fr) Méthode pour la quantification de l'activité de liaison des protéines de liaison d'ADN
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
CA2549066A1 (fr) Diagnostic du syndrome coronarien aigu par la mesure des concentrations de papp-a libre
WO2004039963A8 (fr) Anticorps specifiques de substrat-1/2 (ser 1101/ser1149) de recepteur d'insuline phosphoryle et utilisations associees
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
SE0301058D0 (sv) Method and kit for cell analyte assay
DE59903720D1 (de) Rezeptorbindungsassays und reagenziensatz zum nachweis von tsh-rezeptor-autoantikörpern
ATE484748T1 (de) Testverfahren zur bestimmung von analyten mittels analytanalogen
WO2009069488A1 (fr) Matériel d'essai pour une immunochromatographie